Posted by Michael Wonder on 02 Feb 2023
FDA approves first oral treatment for anaemia caused by chronic kidney disease for adults on dialysis
1 February 2023 - Today, the US FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anaemia caused by chronic kidney disease for adults who have been receiving dialysis for at least four months. Jesduvroq is not approved for patients who are not on dialysis.
Other FDA approved treatments for this condition are injected into the blood or under the skin.
